Leukocytapheresis in pediatric patients with ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 1, 2011, Pages 34-39

  Tomomasa, Takeshi ^a   Tajiri, Hitoshi ^b   Kagimoto, Seiichi ^c   Shimizu, Toshiaki ^d   Yoden, Atsushi ^e   Ushijima, Kosuke ^f   Uchida, Keiichi ^g   Kaneko, Hiroaki ^h   Abukawa, Daiki ⁱ   Konno, Mutsuko ^j   Maisawa, Shun Ichi ^k   Kohsaka, Takao ^l   Kobayashi, Akio ^m  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f KURUME UNIVERSITY MEDICAL CENTER   (Japan)

^g MIE UNIVERSITY HOSPITAL   (Japan)

^h Mirai Children's Clinic   (Japan)

ⁱ MIYAGI CHILDREN S HOSPITAL   (Japan)

^j Sapporo Kosei General Hospital   (Japan)

^k Morioka Children's Hospital   (Japan)

^l Tokyo west Tokushukai Hospital   (Japan)

^m SHOWA UNIVERSITY   (Japan)

more..

Author keywords

apheresis; calprotectin; children; prospective study; remission

Indexed keywords

CALGRANULIN; STEROID;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CHILD; CYTAPHERESIS; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMATOCHEZIA; HEMATOCRIT; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT SAFETY; PATIENT SELECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADOLESCENT; BODY WEIGHT; CHILD; COLITIS, ULCERATIVE; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FECES; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSION; LEUKAPHERESIS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PREDNISOLONE; SEVERITY OF ILLNESS INDEX;

EID: 79959813173     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31821058bc     Document Type: Article

References (29)

1. Shibata H, Kuriyama T, Yamawaki N. Cellsorba. Ther Apher Dial 2003;7:44-7. (Pubitemid 36648042)
2. Sawada K, Ohnishi K, Fukui S, et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 1995;30:322-9.
3. Andoh A, Tsujikawa T, Hata K, et al. Elevated circulating plateletderived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005;100:2042-8.
4. Fukunaga K, Fukuda Y, Yokoyama Y, et al. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients. J Gastroenterol 2006; 41:524-32. (Pubitemid 44138193)
5. Hanai H, Iida T, Takeuchi K, et al. Decrease of reactive-oxygenproducing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 2005;11:3085-90. (Pubitemid 40790668)
6. Andoh A, Tsujikawa T, Inatomi O, et al. Leukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis. Ther Apher Dial 2005;9:270-6. (Pubitemid 41099515)
7. Mitsuyama K, Suzuki A, Matsumoto S, et al. Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis. Clin Exp Immunol 2005;141:130-40. (Pubitemid 40904650)
8. Andoh A, Ogawa A, Kitamura K, et al. Suppression of interleukin- 1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol 2004;39:1150-7. (Pubitemid 40074280)
9. Sawada K, Muto T, Shimoyama T, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-21. (Pubitemid 36131725)
10. Sawada K, Kusugami K, SuzukiY, et al. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005;100:1362-9. (Pubitemid 40904363)
11. Mitsuyama K, Yamasaki H, Kuwaki K, et al. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. Curr Pharm Des 2009;15:2110-9.
12. Matsumoto T, Andoh A, Okawa K, et al. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Ther Apher Dial 2008;12:484-90.
13. Nishioka C, Aoyama N, Maekawa S, et al. Leukocytapheresis therapy for steroid-naive patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. J Gastroenterol Hepatol 2005;20:1567-71. (Pubitemid 43961112)
14. Research Group for Intractable Inflammatory Bowel Disease 2006. Guidelines for the management of ulcerative colitis in Japan. IBD Res 2010;4:189-239.
15. Kumagai M, Yamato Y, Maeda K, et al. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis. Pediatr Int 2007; 49:431-6. (Pubitemid 46961846)
16. Mori K, Yoshihara T, Ando T, et al. Cytapheresis therapy for ulcerative colitis in three pediatric patients. J Pediatr Gastroenterol Nutr 2004;39:549-51.
17. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330: 1841-5. (Pubitemid 24188135)
18. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;30:393-407.
19. Tomomasa T, Kobayashi A, Ushijima K, et al. Guidelines for treatment of ulcerative colitis in children. Pediatr Int 2004;46: 494-6. (Pubitemid 39119173)
20. Danese S, Angelucci E, Stefanelli T, et al. Cytapheresis in inflammatory bowel diseases: current evidence and prospective. Digestion 2008;77: 96-107. (Pubitemid 351556387)
21. Tomomasa T, Kobayashi A, Kaneko H, et al. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 2003;48:750-4. (Pubitemid 36390679)
22. Ikeda H, Ishimaru Y, Takayasu H, et al. Efficacy of granulocyte apheresis in pediatric patients with ulcerative colitis: a pilot study. J Pediatr Gastroenterol Nutr 2006;43:592-6. (Pubitemid 44863683)
23. Ruuska T, Wewer V, Lindgren F, et al. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives. Inflamm Bowel Dis 2009;15: 1049-54.
24. Navarro F, Hanauer SB. Treatment of inflammatory bowel disease: safety and tolerability issues. Am J Gastroenterol 2003;98:S18-23. (Pubitemid 38044603)
25. Turner D. Severe acute ulcerative colitis: the pediatric perspective. Dig Dis 2009;27:322-6.
26. Garud S, Brown A, Cheifetz A, et al. Meta-analysis of the placebo response in ulcerative colitis. Dig Dis Sci 2008;53:875-91. (Pubitemid 351379818)
27. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989;298:82-6. (Pubitemid 19032930)
28. SchroederKW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9. (Pubitemid 18010466)
29. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-32. (Pubitemid 47193130)